Viewing Study NCT00140894


Ignite Creation Date: 2025-12-25 @ 1:45 AM
Ignite Modification Date: 2025-12-26 @ 12:03 AM
Study NCT ID: NCT00140894
Status: TERMINATED
Last Update Posted: 2019-09-20
First Post: 2005-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2002-08-06
Start Date Type: ACTUAL
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2004-10-11
Completion Date Type: ACTUAL
First Submit Date: 2005-08-30
First Submit QC Date: None
Study First Post Date: 2005-09-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-09-18
Last Update Post Date: 2019-09-20
Last Update Post Date Type: ACTUAL